Perfil
Robert J.
Garland is currently a Director at Cardioxyl Pharmaceuticals LLC.
He previously worked as a Director at Novalar Pharmaceuticals, Inc., Zyngenia, Inc., Trevena, Inc., Sagimet Biosciences, Inc., Cleave Therapeutics, Inc., and Surface Oncology, Inc. He also worked as a Principal at McKinsey & Co., Inc. and a Venture Partner at NEA Management Co. LLC.
Garland received his undergraduate degree from Rice University, his graduate degree and MBA from the University of California, Berkeley, and his doctorate from Baylor College of Medicine.
Cargos activos de Robert J. Garland
| Empresas | Cargo | Inicio |
|---|---|---|
Cardioxyl Pharmaceuticals LLC
Cardioxyl Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Discovers and develops therapies and technologies for the treatment of cardiovascular diseases | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Robert J. Garland.
| Empresas | Cargo | Fin |
|---|---|---|
| SURFACE ONCOLOGY, INC. | Director/Miembro de la Junta | - |
| SAGIMET BIOSCIENCES INC. | Director/Miembro de la Junta | - |
Cleave Therapeutics, Inc.
Cleave Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops medicine for oncology and neurodegeneration treatment | Director/Miembro de la Junta | - |
Novalar Pharmaceuticals, Inc.
Novalar Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Director/Miembro de la Junta | - |
Zyngenia, Inc.
Zyngenia, Inc. Drugstore ChainsRetail Trade Develops new class of biotherapeutics | Director/Miembro de la Junta | - |
Formación de Robert J. Garland.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 12 |
|---|---|
Novalar Pharmaceuticals, Inc.
Novalar Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Cardioxyl Pharmaceuticals LLC
Cardioxyl Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Discovers and develops therapies and technologies for the treatment of cardiovascular diseases | Health Technology |
Zyngenia, Inc.
Zyngenia, Inc. Drugstore ChainsRetail Trade Develops new class of biotherapeutics | Retail Trade |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Rice University
Rice University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NEA Management Co. LLC
NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates seeks invests in companies located across the globe. The firm targets companies operating in the fields of technology (software & services, systems, consumer & internet, energy), healthcare (biopharms, devices, services). The firm provides financing for seed, early and growth stage capital requirements. | Finance |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baylor College of Medicine
Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trevena, Inc.
Trevena, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on the development and commercialization of novel medicines for patients affected by central nervous system | Health Technology |
Sagimet Biosciences, Inc.
Sagimet Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for the treatment of infectious diseases | Health Technology |
Cleave Therapeutics, Inc.
Cleave Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops medicine for oncology and neurodegeneration treatment | Health Technology |
Surface Oncology, Inc.
Surface Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage immuno-oncology company that develops cancer therapies | Health Technology |
- Bolsa de valores
- Insiders
- Robert J. Garland
















